Secondly, although this study confirmed that targeting CD44 in photoimmunotherapy results in increased tumour distribution and enhanced antitumour effects with intratumoural administration, it is possible that if a more tumour-specific target had been used, the difference between intravenous and intratumoural administration might have been smaller. The gene discussed is CD44; the disease is neoplasm.